People

Hyun Tae Kim, also styled Kim Hyun Tae in the manager’s legacy English roster, was a generalmanager and bio-investment leader at SouthKorea’s MiraeAssetCapital. Acticor’s2018 funding announcement and2021 regulator-approved registration independently identify him as its boardobserver representing the Koreaninvestor. The2021biography reports that he joinedMirae in2017, following nineyears of pharma/biotechnology/medicaldevice equityresearch and fouryears in pharmaceutical licensing/development. It lists a BachelorofScience fromtheUniversityofCalifornia,Davis, and aMasterofScience fromKAIST (KoreaAdvancedInstituteofScienceandTechnology). The affiliation is historical; he is absent fromthecurrent2026directory and no currentmanagerrole is asserted. No independentlymatched originalportrait was found; he is distinct from currentMJ Kim and otherKim homonyms.

Roles

Mirae Asset Capital

Bio Investment General Manager / former team leader (historical, confirmed2018–2021)

Current
Acticor Biotech

Board Observer representing Mirae Asset Capital (historical, own2021 statutory roster)

Current